Trial intelligence / Profile preview

PK Interaction of Diclofenac and Tramadol FDC in Healthy Subjects

NCT03766984Phase 1Completed

Sponsor
Grünenthal GmbH
Start
Jun 2015
Primary completion
Jun 2015
Modality
Small Molecules
Countries
1
01

Overview

Phase 1, randomised, open-label trial of diclofenac and tramadol in pain (2 arms), sponsored by Grünenthal GmbH. Primary endpoints: Maximum Plasma Concentration at 36 hours and Area Under the Plasma Concentration Curve from Administration to Time t at 36 hours. Started Jun 2015; status: completed.

02

Drugs

diclofenactramadol
03

Conditions

pain

Beyond the preview

Go deeper on NCT03766984.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03766984.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call